MDT · News · 20261021N
Diabetes Business Separation
Medtronic plc · 2026-10-21 · Importance 47 · Surprise 42 · In source text
Medtronic was reported to be completing the separation of MiniMed. The transaction is restructuring the company’s revenue mix by separating the diabetes business from the remaining medical-device portfolio. The separation was cited alongside first-quarter fiscal 2027 revenue of $9.76 billion.
Key facts
- Medtronic reported first-quarter fiscal 2027 revenue of USD 9.76 billion. source
- Medtronic was reported to be completing the separation of MiniMed, restructuring its revenue mix. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Medtronic reported first-quarter fiscal 2027 revenue of USD 9.76 billion. |